The Combination of Ruxolitinib (RUX) with Decitabine (DAC) in Patients (Pts) with Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia (post-MPN AML): Interim Report of a Phase I/II Trial
暂无分享,去创建一个
Z. Estrov | H. Kantarjian | G. Garcia-Manero | S. Verstovsek | Xuelin Huang | T. Kadia | F. Ravandi | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | S. Kornblau | R. Assi | N. Pemmaraju | N. Jain | Y. Alvarado | M. Brandt | P. Bose | Yvonne Gasior